batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Innovent pushes its pancreatic hope 21 July 2025 KAT6 marks another phase 1-to-3 push from Pfizer 17 July 2025 Another try with patri-dxd 17 July 2025 Debiopharm picks up a bargain-basement Wee1 companion 16 July 2025 Essa succumbs to Xoma 15 July 2025 Atara turns $60m into $40m 14 July 2025 Actithera hopes to do FAP differently 10 July 2025 Not the zanza trial some were looking for 10 July 2025 Load More